Can’t Wait? Your Impatience May Be Genetic — And Linked To 212 Health Conditions

We’ve all heard that ‘patience is a virtue,’ but is impatience a health risk?

Would you take $50 today or wait a month for $100? Your answer reveals more about your health than you might expect. Scientists have discovered that the ability to delay gratification is partly written in our DNA, and people who struggle to wait are more likely to develop problems like addiction, obesity, heart disease, chronic pain, and earlier health issues.

A genetic study of nearly 135,000 people pinpoints 11 locations in human DNA linked to this trait, called delay discounting. The findings reveal that impatience isn’t just a personality quirk or a matter of willpower. It’s heritable and has biological roots that show up across many areas of mental and physical health.

Researchers from the University of California San Diego and 23andMe had participants complete a simple questionnaire with 27 different monetary choices. Someone who consistently picks immediate smaller rewards over larger future ones shows “steeper discounting.” The team identified numerous genetic regions tied to this behavior, with genes clustering in areas already known to influence risk-taking, intelligence, body weight, and psychiatric conditions.

Common genetic variants account for about 10% of the variation in how people value immediate versus delayed rewards. While environmental factors play a major role, this genetic component stays stable across a person’s lifespan.

Genes That Shape the ‘Now or Later’ Decision

One major finding involved chromosome 6, where a genetic variant sits between two genes previously linked to risk-taking, smoking, alcohol use, bipolar disorder, and body mass index. Another hotspot on chromosome 16 contained 18 genes that influence brain growth, intelligence, and eating behaviors. Disruptions in this region have been implicated in autism, ADHD, schizophrenia, and obesity.

One gene, SULT1A1, produces an enzyme induced by dopamine in brain cells. Dopamine has long been studied in reward and decision-making, and this genetic link fits with that research. Another gene, SH2B1, helps regulate brain growth. Mice bred without this gene show brain growth problems and aggressive behavior.

The study, published in Molecular Psychiatry, shows that the genetic relationship with impatience wasn’t always straightforward. While steeper discounting was found to be linked genetically to higher risks for smoking, ADHD, depression, and obesity, it showed the opposite pattern for obsessive-compulsive disorder, anorexia, autism, schizophrenia, and bipolar disorder. People genetically predisposed to these conditions tended to prefer waiting for larger rewards. Both extremes carry health risks.

Intelligence and education showed the strongest genetic overlap with delay discounting. But when researchers mathematically removed these factors, 19 associations remained, including links to smoking, body weight, brain connectivity patterns, digestive disorders, and chronic pain. Some genetic influences on impatience are still there even after accounting for intelligence and education.

Genetic Risk Predicts Over 200 Medical Conditions

To test whether these genetic findings translate to real-world health, researchers calculated delay discounting genetic risk scores for nearly 67,000 patients in Vanderbilt University Medical Center’s health records. Higher genetic risk for steep discounting associated with 212 different medical diagnoses.

Beyond expected links to tobacco use and mood disorders, the genetic risk connected to respiratory conditions like chronic airway obstruction, heart disease, Type 2 diabetes, digestive issues, and chronic pain.

Age patterns emerged too. Young adults with higher genetic risk faced more pregnancy complications. Middle-aged adults showed associations with substance use disorders, depression, diabetes, and obesity. Older adults demonstrated primarily cardiovascular associations, including heart attacks and coronary artery disease.

Many associations weakened when researchers accounted for smoking, suggesting that cigarettes might explain some health consequences of impatience. However, associations with vision problems, skin conditions, and certain cancers persisted, indicating that multiple pathways link impatience to health.

Screening For Impatience and Impulsivity

People with steeper discounting show higher relapse rates when trying to quit smoking. If impatience has identifiable biological roots, future treatments might be able to tap into those pathways, even though we’re not there yet.

However, thousands of genetic variants each contribute tiny effects. No single gene provides enough information to predict whether someone will struggle with impatience. Simple genetic tests won’t answer that question.

“Understanding the genetic and biological roots of delay discounting opens up many new possibilities,” says the study’s senior author Sandra Sanchez-Roige, associate professor of psychiatry at UC San Diego School of Medicine, in a statement. “In the future, delay discounting could become a clinically useful marker, one that helps us improve behavioral and pharmacological treatments aimed at impulsivity.”

Different types of impulsive behavior have different biological underpinnings. Someone might show impatience with delayed rewards but not necessarily act without thinking or take physical risks.

Environmental factors matter enormously. Socioeconomic stress, trauma, substance use, and life experiences all shape how people make decisions about time. Growing up in poverty or experiencing chronic stress can reasonably shift someone toward favoring immediate rewards.

Some health associations tied to delay discounting might reflect consequences of disadvantageous behaviors rather than direct biological links. People who heavily discount the future may smoke, overeat, or avoid preventive medical care, which are all behaviors with immediate benefits but long-term costs.

Delay discounting connects psychiatric and physical health in ways that traditional diagnostic categories miss, influencing health trajectories across decades and across seemingly unrelated medical domains.

---